New Asthma Inhaler Shows Big Promise in Late-Stage TrialsAstraZeneca's Breztri Aerosphere shows significant improvements in asthma treatment, outperforming dual therapies in clinical trials.
New Treatment Could Stop Cold Sores and Shingles Before They StartNew treatment GS-1 shows promise against shingles and cold sores, potentially reducing symptoms and transmission of these viral infections.
Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDAThe FDA has delayed Novavax's COVID-19 vaccine approval, requiring more trials to prove its effectiveness after external interference.
Pfizer Ends Obesity Drug Trial After Liver Risk EmergesPfizer halts development of danuglipron for obesity treatment due to liver injury concerns despite exploring various dosages.
Corcept’s New Cancer Pill Boosts Survival for Drug-Resistant PatientsCorcept's Relacorilant shows promise in treating platinum-resistant ovarian cancer, extending survival by 4.5 months in trials.
New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side EffectsEli Lilly's Lepodisiran shows a 93.9% reduction in lipoprotein levels, a key heart disease risk factor, in mid-stage trials.
Are Probiotics Overrated? Experts Urge Caution Over Gut Health ClaimsProbiotics may not be as effective as believed; a high-fiber diet is recommended for gut health instead, according to Dr. Pasricha.
CagriSema Fails to Meet Expectations in Late-Stage Obesity Trial, but Still Beats PlaceboNovo Nordisk's CagriSema obesity treatment underperformed in trials, showing lower weight loss than anticipated compared to Wegovy.
Elevated Amino Acids in Lungs Could Fuel Cancer Growth, New Study FindsA study reveals that high levels of aspartate in the lungs promote cancer cell growth, suggesting new prevention strategies for lung cancer.
MSD's Bold HIV Drug Combo: Could It Be the Future of Treatment?MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent expiration.
Sammy Basso, World's Longest-Living Progeria Patient, Dies at 28Sammy Basso, a prominent advocate and the world’s longest-living survivor of the rare genetic disorder progeria, has died at the age of 28.
New Asthma Inhaler Shows Big Promise in Late-Stage Trials AstraZeneca's Breztri Aerosphere shows significant improvements in asthma treatment, outperforming dual therapies in clinical trials.
New Treatment Could Stop Cold Sores and Shingles Before They Start New treatment GS-1 shows promise against shingles and cold sores, potentially reducing symptoms and transmission of these viral infections.
Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA The FDA has delayed Novavax's COVID-19 vaccine approval, requiring more trials to prove its effectiveness after external interference.
Pfizer Ends Obesity Drug Trial After Liver Risk Emerges Pfizer halts development of danuglipron for obesity treatment due to liver injury concerns despite exploring various dosages.
Corcept’s New Cancer Pill Boosts Survival for Drug-Resistant Patients Corcept's Relacorilant shows promise in treating platinum-resistant ovarian cancer, extending survival by 4.5 months in trials.
New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects Eli Lilly's Lepodisiran shows a 93.9% reduction in lipoprotein levels, a key heart disease risk factor, in mid-stage trials.
Are Probiotics Overrated? Experts Urge Caution Over Gut Health Claims Probiotics may not be as effective as believed; a high-fiber diet is recommended for gut health instead, according to Dr. Pasricha.
CagriSema Fails to Meet Expectations in Late-Stage Obesity Trial, but Still Beats Placebo Novo Nordisk's CagriSema obesity treatment underperformed in trials, showing lower weight loss than anticipated compared to Wegovy.
Elevated Amino Acids in Lungs Could Fuel Cancer Growth, New Study Finds A study reveals that high levels of aspartate in the lungs promote cancer cell growth, suggesting new prevention strategies for lung cancer.
MSD's Bold HIV Drug Combo: Could It Be the Future of Treatment? MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent expiration.
Sammy Basso, World's Longest-Living Progeria Patient, Dies at 28 Sammy Basso, a prominent advocate and the world’s longest-living survivor of the rare genetic disorder progeria, has died at the age of 28.
Hot Topics